Todor Totev

13PUBLICATIONS

33CO-AUTHORS

Psychological methodology, design and analysisCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPharmacogenomicsMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 12, 2026

Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis.

|Apr 01, 2026

Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Review.

Matheus Sewastjanow-Silva, Mok Oh, Lawrence Chang

|Mar 23, 2026

Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United Kingdom.

Axel Heinze, Shazia K Afridi, Todor I Totev

|Jun 13, 2025

Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study.

Maen Abdelrahim, Abdullah Esmail, Richard D Kim

|Sep 14, 2022

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey.

Maryia Zhdanava, H Lynn Starr, Todor I Totev

|Aug 26, 2022

Assessment of the Impact of a Meningitis/Encephalitis Panel on Hospital Length of Stay: A Systematic Review and Meta-Analysis.

Kyle D Hueth, Philippe Thompson-Leduc, Todor I Totev

Pageof 3

Frequent Collaborators

Mei Sheng Duh

Beilei Cai

H Lynn Starr

Dominic Pilon

Emily K Bergsland

Arvind Dasari

Al B Benson

Mei Sheng Duh

Susan Giacalone

Brian A Van Tine

Frequent Collaborators

Mei Sheng Duh

Beilei Cai

H Lynn Starr

Dominic Pilon